Minnesota releases a report on the 340B Drug Pricing Program, highlighting the need for transparency in healthcare economics.

Minnesota has becomes the first state to release a report examining the 340B drug discount program for "safety-net" hospitals ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...

University of Minnesota researchers detail the loopholes and pitfalls of drug companies’ discounted pricing program and what Minnesota entities are doing to enhance transparency. The 340B Drug Pricing ...

Johnson and Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and ...

A first-of-its-kind state report shows safety-net hospitals and health care providers in Minnesota saw $630 million in extra revenue last year — and probably much more — from an obscure program funded ...

As the federal drug discount program known as 340B has seen rapid growth in recent years, Minnesota's Department of Health is looking to shine a light on where that growth is occurring.The first year ...

Hospitals belonging to Nashville, Tennessee-based HCA Healthcare, Dallas-based Tenet Healthcare, St. Louis-based Ascension, New York-based Mount Sinai Health System, Rochester, Minnesota-based ...

Kelly Morrison (D), Minnesota’s 3rd District ... use of some psychedelic substances for people 21 and older. 340B: California voters will choose whether the state should further scrutinize ...

Minnesota-based nonprofit health system selected ... there's a lot of impact there to specialty drug pricing and 340B. And so it seems like the IRA is causing a lot of changes to that part of ...